Position in ACB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$206,990
+$45,815 QoQ
Shares Held
74,190
+50.5% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 149 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. ACB ranks #41 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
2,076,260 | $349,932,860 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,775,349 | $67,753,490 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,184,378 | $55,085,420 | |
| 4 | ALKS |
Alkermes plc.
|
1,038,311 | $54,407,496 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
561,480 | $35,906,646 | |
| 6 | ZTS |
Zoetis Inc.
|
386,428 | $27,768,716 | |
| 7 | LQDA |
Liquidia Corp
|
266,829 | $21,274,276 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
4,556,089 | $19,181,134 |
All Filings in ACB
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $206,990 | 74,190 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $161,175 | 49,289 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,254,219 | 771,142 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,853,219 | 1,149,869 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $64,901 | 15,307 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $66,280 | 15,098 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $210,362 | 35,776 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $353,771 | 76,574 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $615,227 | 140,143 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $793,156 | 1,666,296 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $136,007 | 232,492 | Shares | Sole | 2023-11-14 | |
| 2022-09-30 | $222,396 | 182,292 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,319,893 | 2,515,071 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,510,564 | 1,877,641 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $63,010 | 11,647 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $80,597 | 11,647 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $105,288 | 11,647 | Shares | Sole | 2021-08-16 | |
| 2020-03-31 | $953,863 | 1,052,830 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||